Charles Glasier
Concepts (202)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain | 16 | 2023 | 1387 | 1.560 |
Why?
| Magnetic Resonance Imaging | 19 | 2021 | 1604 | 1.110 |
Why?
| Tomography, X-Ray Computed | 6 | 2021 | 1213 | 1.070 |
Why?
| Radiation Dosage | 5 | 2021 | 170 | 0.970 |
Why?
| Optic Nerve | 3 | 2014 | 46 | 0.650 |
Why?
| Sturge-Weber Syndrome | 1 | 2017 | 9 | 0.620 |
Why?
| Hypopituitarism | 2 | 2014 | 16 | 0.600 |
Why?
| Eye Abnormalities | 2 | 2014 | 22 | 0.600 |
Why?
| Pituitary Gland | 2 | 2014 | 78 | 0.570 |
Why?
| Diffusion Tensor Imaging | 7 | 2023 | 97 | 0.560 |
Why?
| Hematoma, Epidural, Cranial | 1 | 2015 | 7 | 0.550 |
Why?
| Sinus Thrombosis, Intracranial | 1 | 2015 | 20 | 0.540 |
Why?
| Phlebography | 1 | 2015 | 70 | 0.530 |
Why?
| Intracranial Hemorrhages | 1 | 2015 | 41 | 0.530 |
Why?
| Magnetic Resonance Angiography | 1 | 2015 | 80 | 0.520 |
Why?
| Neuroimaging | 1 | 2015 | 88 | 0.510 |
Why?
| Brain Injuries | 4 | 2023 | 183 | 0.510 |
Why?
| Aicardi Syndrome | 1 | 2014 | 3 | 0.500 |
Why?
| Ketones | 1 | 2014 | 9 | 0.500 |
Why?
| Child | 21 | 2023 | 7341 | 0.490 |
Why?
| Spasms, Infantile | 1 | 2014 | 30 | 0.480 |
Why?
| Brain Diseases | 3 | 2013 | 87 | 0.470 |
Why?
| Child, Preschool | 16 | 2023 | 4147 | 0.430 |
Why?
| Spinal Dysraphism | 1 | 2011 | 34 | 0.410 |
Why?
| Attention | 1 | 2011 | 185 | 0.380 |
Why?
| Diffusion Magnetic Resonance Imaging | 3 | 2022 | 126 | 0.360 |
Why?
| Infant | 12 | 2023 | 3817 | 0.350 |
Why?
| Infant, Newborn | 11 | 2023 | 2907 | 0.340 |
Why?
| Demyelinating Diseases | 1 | 2008 | 7 | 0.330 |
Why?
| Humans | 37 | 2023 | 54284 | 0.310 |
Why?
| Neurodegenerative Diseases | 1 | 2008 | 83 | 0.300 |
Why?
| Optic Nerve Diseases | 2 | 2008 | 27 | 0.290 |
Why?
| Ocular Motility Disorders | 2 | 2007 | 21 | 0.290 |
Why?
| Female | 23 | 2023 | 28441 | 0.280 |
Why?
| Male | 21 | 2020 | 27334 | 0.260 |
Why?
| Brain Mapping | 4 | 2021 | 250 | 0.230 |
Why?
| Sodium, Dietary | 1 | 2023 | 27 | 0.230 |
Why?
| Strabismus | 2 | 2008 | 19 | 0.230 |
Why?
| Wounds and Injuries | 2 | 2017 | 321 | 0.230 |
Why?
| Diagnosis, Differential | 6 | 2015 | 1136 | 0.220 |
Why?
| Visual Cortex | 1 | 2002 | 12 | 0.210 |
Why?
| Blindness, Cortical | 1 | 2002 | 5 | 0.210 |
Why?
| Visual Pathways | 1 | 2002 | 10 | 0.210 |
Why?
| Cognition | 2 | 2022 | 348 | 0.210 |
Why?
| Trauma Centers | 3 | 2018 | 218 | 0.210 |
Why?
| Craniocerebral Trauma | 1 | 2023 | 89 | 0.210 |
Why?
| Mothers | 2 | 2023 | 247 | 0.200 |
Why?
| Optic Disk | 1 | 2002 | 25 | 0.200 |
Why?
| Depressive Disorder, Major | 1 | 2023 | 159 | 0.200 |
Why?
| Meningitis, Haemophilus | 1 | 2021 | 9 | 0.200 |
Why?
| Vasospasm, Intracranial | 1 | 2021 | 17 | 0.190 |
Why?
| Child Abuse | 1 | 2023 | 170 | 0.190 |
Why?
| Adolescent | 9 | 2017 | 6897 | 0.180 |
Why?
| Depression | 2 | 2023 | 595 | 0.170 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2020 | 173 | 0.170 |
Why?
| Anxiety | 1 | 2020 | 279 | 0.160 |
Why?
| Cross-Sectional Studies | 4 | 2017 | 1693 | 0.160 |
Why?
| Heart Defects, Congenital | 2 | 2015 | 608 | 0.160 |
Why?
| Meninges | 1 | 2017 | 13 | 0.160 |
Why?
| Sepsis | 1 | 2021 | 251 | 0.160 |
Why?
| Sensitivity and Specificity | 3 | 2015 | 923 | 0.150 |
Why?
| Registries | 2 | 2017 | 553 | 0.150 |
Why?
| Retrospective Studies | 7 | 2023 | 6432 | 0.140 |
Why?
| Cerebral Ventriculography | 1 | 2015 | 3 | 0.140 |
Why?
| False Positive Reactions | 1 | 2015 | 68 | 0.140 |
Why?
| Cerebral Ventricles | 1 | 2015 | 25 | 0.130 |
Why?
| Cerebrospinal Fluid Shunts | 1 | 2015 | 19 | 0.130 |
Why?
| Hydrocephalus | 1 | 2015 | 41 | 0.130 |
Why?
| Reproducibility of Results | 2 | 2015 | 1304 | 0.120 |
Why?
| Hypercapnia | 1 | 2014 | 17 | 0.120 |
Why?
| Anti-Inflammatory Agents | 2 | 2012 | 175 | 0.120 |
Why?
| Internet | 1 | 2016 | 275 | 0.120 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2015 | 69 | 0.120 |
Why?
| Image Processing, Computer-Assisted | 2 | 2012 | 256 | 0.120 |
Why?
| Young Adult | 4 | 2019 | 4318 | 0.110 |
Why?
| Migraine with Aura | 1 | 2012 | 4 | 0.110 |
Why?
| Brain Edema | 1 | 2012 | 39 | 0.110 |
Why?
| Heart Septal Defects, Ventricular | 1 | 2012 | 36 | 0.110 |
Why?
| Task Performance and Analysis | 1 | 2011 | 61 | 0.100 |
Why?
| Pediatrics | 1 | 2015 | 323 | 0.100 |
Why?
| Carotid Artery, Internal, Dissection | 1 | 2011 | 8 | 0.100 |
Why?
| Ketamine | 1 | 2012 | 61 | 0.100 |
Why?
| Cardiopulmonary Bypass | 1 | 2012 | 97 | 0.100 |
Why?
| Cavernous Sinus | 1 | 2011 | 15 | 0.100 |
Why?
| Meningomyelocele | 1 | 2011 | 16 | 0.100 |
Why?
| Heart Diseases | 1 | 2014 | 237 | 0.100 |
Why?
| Respiration, Artificial | 1 | 2014 | 285 | 0.100 |
Why?
| Tuberous Sclerosis | 1 | 2011 | 37 | 0.100 |
Why?
| Arnold-Chiari Malformation | 1 | 2011 | 23 | 0.100 |
Why?
| Executive Function | 1 | 2011 | 80 | 0.100 |
Why?
| Neuroprotective Agents | 1 | 2012 | 125 | 0.100 |
Why?
| Spinal Nerve Roots | 1 | 2010 | 12 | 0.100 |
Why?
| Intracranial Aneurysm | 1 | 2011 | 54 | 0.100 |
Why?
| Guillain-Barre Syndrome | 1 | 2010 | 12 | 0.100 |
Why?
| Pregnancy | 3 | 2023 | 2620 | 0.100 |
Why?
| Imaging, Three-Dimensional | 1 | 2011 | 171 | 0.100 |
Why?
| Rhabdoid Tumor | 1 | 2009 | 8 | 0.090 |
Why?
| Central Nervous System Neoplasms | 1 | 2009 | 57 | 0.090 |
Why?
| Meningeal Neoplasms | 1 | 2009 | 50 | 0.090 |
Why?
| Anisotropy | 2 | 2022 | 63 | 0.080 |
Why?
| Receptors, Somatostatin | 1 | 2008 | 2 | 0.080 |
Why?
| Rhombencephalon | 1 | 2007 | 4 | 0.080 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 57 | 0.080 |
Why?
| Prospective Studies | 3 | 2020 | 2604 | 0.080 |
Why?
| Inflammation | 1 | 2012 | 674 | 0.080 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2008 | 253 | 0.080 |
Why?
| Preoperative Care | 2 | 2021 | 184 | 0.070 |
Why?
| Mitochondrial Diseases | 1 | 2008 | 109 | 0.070 |
Why?
| Cerebellum | 1 | 2007 | 142 | 0.070 |
Why?
| Injury Severity Score | 2 | 2017 | 178 | 0.070 |
Why?
| Treatment Outcome | 2 | 2014 | 5604 | 0.070 |
Why?
| Child Development | 2 | 2020 | 204 | 0.060 |
Why?
| Electroencephalography | 3 | 2015 | 356 | 0.060 |
Why?
| Visual Acuity | 2 | 2003 | 143 | 0.060 |
Why?
| Brain Neoplasms | 1 | 2008 | 284 | 0.060 |
Why?
| Neuronal Ceroid-Lipofuscinoses | 1 | 2004 | 6 | 0.060 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2004 | 9 | 0.060 |
Why?
| Retinal Degeneration | 1 | 2004 | 16 | 0.060 |
Why?
| Neoplasm Recurrence, Local | 1 | 2008 | 644 | 0.060 |
Why?
| Exons | 1 | 2004 | 105 | 0.060 |
Why?
| Molecular Chaperones | 1 | 2004 | 64 | 0.060 |
Why?
| Optic Chiasm | 1 | 2003 | 8 | 0.060 |
Why?
| Retinal Hemorrhage | 1 | 2023 | 16 | 0.060 |
Why?
| Optic Atrophy, Hereditary, Leber | 1 | 2003 | 5 | 0.060 |
Why?
| Hematoma, Subdural | 1 | 2023 | 27 | 0.060 |
Why?
| Chromosome Deletion | 1 | 2004 | 150 | 0.060 |
Why?
| Membrane Glycoproteins | 1 | 2004 | 269 | 0.050 |
Why?
| Haemophilus influenzae | 1 | 2021 | 21 | 0.050 |
Why?
| Ventriculoperitoneal Shunt | 1 | 2021 | 28 | 0.050 |
Why?
| Language | 1 | 2021 | 138 | 0.050 |
Why?
| Functional Laterality | 2 | 2012 | 99 | 0.050 |
Why?
| Adult | 5 | 2020 | 14207 | 0.050 |
Why?
| Pilot Projects | 2 | 2014 | 808 | 0.050 |
Why?
| Diet | 1 | 2023 | 598 | 0.040 |
Why?
| Infant, Premature | 1 | 2002 | 335 | 0.040 |
Why?
| Arkansas | 2 | 2016 | 2100 | 0.040 |
Why?
| Neurologic Examination | 2 | 2012 | 76 | 0.040 |
Why?
| Fetal Diseases | 1 | 2018 | 54 | 0.040 |
Why?
| Prenatal Diagnosis | 1 | 2018 | 108 | 0.040 |
Why?
| Crohn Disease | 1 | 2018 | 96 | 0.040 |
Why?
| Body Burden | 1 | 2016 | 12 | 0.040 |
Why?
| Retreatment | 1 | 2016 | 57 | 0.040 |
Why?
| Electroretinography | 2 | 2008 | 20 | 0.040 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2016 | 42 | 0.040 |
Why?
| Attitude to Health | 1 | 2018 | 226 | 0.040 |
Why?
| Demography | 1 | 2016 | 99 | 0.040 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2018 | 434 | 0.030 |
Why?
| Hospitals, Pediatric | 1 | 2017 | 272 | 0.030 |
Why?
| Patient Transfer | 1 | 2016 | 103 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 2008 | 531 | 0.030 |
Why?
| DNA, Mitochondrial | 2 | 2008 | 186 | 0.030 |
Why?
| Nerve Fibers, Myelinated | 1 | 2014 | 27 | 0.030 |
Why?
| Infant, Extremely Low Birth Weight | 1 | 2014 | 30 | 0.030 |
Why?
| Ophthalmoscopy | 1 | 2013 | 19 | 0.030 |
Why?
| Verapamil | 1 | 2012 | 23 | 0.030 |
Why?
| Methylprednisolone | 1 | 2012 | 38 | 0.030 |
Why?
| Intention to Treat Analysis | 1 | 2012 | 28 | 0.030 |
Why?
| Calcium Channels | 1 | 2012 | 59 | 0.030 |
Why?
| Developmental Disabilities | 1 | 2013 | 127 | 0.030 |
Why?
| Sodium-Potassium-Exchanging ATPase | 1 | 2012 | 68 | 0.030 |
Why?
| Calcium Channel Blockers | 1 | 2012 | 72 | 0.030 |
Why?
| Spectroscopy, Near-Infrared | 1 | 2012 | 62 | 0.030 |
Why?
| Injections, Intravenous | 1 | 2012 | 148 | 0.030 |
Why?
| Gait Disorders, Neurologic | 1 | 2012 | 36 | 0.030 |
Why?
| Central Nervous System | 1 | 2012 | 85 | 0.030 |
Why?
| Reference Standards | 1 | 2011 | 63 | 0.030 |
Why?
| Risk Assessment | 1 | 2016 | 1361 | 0.030 |
Why?
| Linear Models | 1 | 2012 | 309 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2012 | 401 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2012 | 159 | 0.020 |
Why?
| Cognition Disorders | 1 | 2012 | 240 | 0.020 |
Why?
| Double-Blind Method | 1 | 2012 | 742 | 0.020 |
Why?
| Chromosomes, Human, Pair 22 | 1 | 2009 | 42 | 0.020 |
Why?
| Prevalence | 1 | 2013 | 1025 | 0.020 |
Why?
| Cardiac Surgical Procedures | 1 | 2013 | 318 | 0.020 |
Why?
| Lumbar Vertebrae | 1 | 2010 | 105 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2013 | 1084 | 0.020 |
Why?
| Nystagmus, Pathologic | 1 | 2008 | 7 | 0.020 |
Why?
| DNA | 1 | 2012 | 581 | 0.020 |
Why?
| Cytokines | 1 | 2012 | 676 | 0.020 |
Why?
| Indium Radioisotopes | 1 | 2008 | 5 | 0.020 |
Why?
| GTP Phosphohydrolases | 1 | 2008 | 35 | 0.020 |
Why?
| Somatostatin | 1 | 2008 | 26 | 0.020 |
Why?
| Cranial Irradiation | 1 | 2008 | 24 | 0.020 |
Why?
| Vision Disorders | 1 | 2008 | 73 | 0.020 |
Why?
| Neoplasms | 1 | 2018 | 1316 | 0.020 |
Why?
| Prognosis | 1 | 2013 | 2118 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2013 | 2387 | 0.020 |
Why?
| Radiation Injuries | 1 | 2008 | 153 | 0.020 |
Why?
| Time Factors | 1 | 2013 | 3213 | 0.020 |
Why?
| Proteins | 1 | 2008 | 376 | 0.020 |
Why?
| Case-Control Studies | 1 | 2008 | 1228 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2008 | 1048 | 0.020 |
Why?
| Risk Factors | 1 | 2013 | 3935 | 0.020 |
Why?
| Microscopy, Electron | 1 | 2004 | 97 | 0.010 |
Why?
| Hypertrophy | 1 | 2003 | 52 | 0.010 |
Why?
| Alleles | 1 | 2004 | 277 | 0.010 |
Why?
| DNA Mutational Analysis | 1 | 2003 | 217 | 0.010 |
Why?
| Biopsy | 1 | 2004 | 692 | 0.010 |
Why?
| Skin | 1 | 2004 | 469 | 0.010 |
Why?
| Muscle, Skeletal | 1 | 2004 | 847 | 0.010 |
Why?
| Middle Aged | 1 | 2008 | 13088 | 0.010 |
Why?
|
|
Glasier's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|